FindTrial
Sign In

neuron specific enolase as prognosis marker in traumatic brain injury

Utility Of Neuron Specific Enolase in Traumatic Brain Injury in Assessing Severity and Outcome in Neuro-Critical Patients. An Observational Study - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074663
Enrollment
100
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S062- Diffuse traumatic brain injury

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

DR SAURAV SHEKHAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria All stroke patients (ischaemic/haemorrhagic) will be included in this study All patients of age group greater than 40 years and of both sexes

Exclusion criteria

Exclusion criteria: patients relatives refusal any patients with sepsis any patients with any neural tumours or any other cancer

Design outcomes

Primary

MeasureTime frame
correlation between NSE levels and injury severity, assessed by NIHSS score at icu admissionTimepoint: at time of admission to icu at 8 weeks—

Secondary

MeasureTime frame
relationship between functional outcome & NSE levels. We will also try to ascertain any cutoff value of the NSE level to predict mortality at 48 h after admission.Timepoint: Baseline , 4 weeks—

Countries

India

Contacts

Public ContactSAURAV SHEKHAR

Indira Gandhi Institute of Medical Sciences

sauravshekhar99@gmail.com9308921568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026